Thesis

258 Appendices Not in this thesis 8. Tuncel H, Visser D, Timmers T, Wolters EE, Ossenkoppele R, van der Flier WM, van Berckel BNM, Boellaard R, Golla SSV. Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline. EJNMMI Res. 2023 Oct 27;13(1):93. doi: 10.1186/s13550-023-01041-x. 9. Schoonhoven DN, Coomans EM, Millán AP, van Nifterick AM, Visser D, Ossenkoppele R, Tuncel H, van der Flier WM, Golla SSV, Scheltens P, Hillebrand A, van Berckel BNM, Stam CJ, Gouw AA. Tau protein spreads through functionally connected neurons in Alzheimer’s disease: a combined MEG/PET study. Brain. 2023 Oct 3;146(10):4040-4054. doi: 10.1093/brain/awad189. 10. Coomans EM, de Koning LA, Rikken RM, Verfaillie SCJ, Visser D, den Braber A, Tomassen J, van de Beek M, Collij LE, Lemstra AW, Windhorst AD, Barkhof F, Golla SSV, Visser PJ, Scheltens P, van der Flier WM, Ossenkoppele R, van Berckel BNM, van de Giessen E. Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies. Neurology. 2023 Nov 7;101(19):e1850-e1862. doi: 10.1212/WNL.0000000000207794. 11. Verveen A, Verfaillie SCJ, Visser D, Csorba I, Coomans EM, Koch DW, Appelman B, Barkhof F, Boellaard R, de Bree G, van de Giessen EM, Golla S, van Heugten CM, Horn J, Hulst HE, de Jong MD, Kuut TA, van der Maaden T, van Os YMG, Prins M, Slooter AJC, Visser-Meily JMA, van Vugt M, van den Wijngaard CC, Nieuwkerk PT, Knoop H, Tolboom N, van Berckel BNM. Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case–control study (VeCosCO). BMJ Open. 2023 Jun 30;13(6):e072611. doi: 10.1136/bmjopen-2023-072611. 12. Heeman F, Visser D, Yaqub MM, Verfaillie SCJ, Timmers T, Pijnenburg YAL, van der Flier WM, van Berckel BNM, Boellaard R, Lammertsma AA, Golla SSV. Precision estimates of relative and absolute cerebral blood flow in Alzheimer’s disease and cognitively normal individuals. J Cereb Blood Flow Metab. 2023 Mar;43(3):369-378. doi: 10.1177/0271678X221135270. 13. Coomans EM, Verberk IMW, Ossenkoppele R, Verfaillie SCJ, Visser D, Gouda M, Tuncel H, Wolters EE, Timmers T, Windhorst AD, Golla SSV, Scheltens P, van WM, Flier D, van Berckel BNM, Teunissen CE. A head-to-head comparison between plasma pTau181 and tau-PET along the Alzheimer’s disease continuum. J Nucl Med. 2023 Mar;64(3):437-443. doi: 10.2967/jnumed.122.264279. 14. Ebenau JL, Visser D, Verfaillie SCJ, Timmers T, van Leeuwenstijn MSSA, Kate MT, Windhorst AD, Barkhof F, Scheltens P, Prins ND, Boellaard R, van der Flier WM, van Berckel BNM. Cerebral blood flow, amyloid burden, and cognition in cognitively

RkJQdWJsaXNoZXIy MjY0ODMw